menu
    • menu

    Company profile for Geron

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Geron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. Imetelstat is a novel, first-in-class telomerase inhibitor exclusively owned by Geron and being developed in hematologic myeloid malignancies. Early clinical data suggest imetelstat may have disease-modifying activity throu...
    Geron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. Imetelstat is a novel, first-in-class telomerase inhibitor exclusively owned by Geron and being developed in hematologic myeloid malignancies. Early clinical data suggest imetelstat may have disease-modifying activity through the suppression of malignant progenitor cell clone proliferation, which allows potential recovery of normal hematopoiesis. Ongoing clinical studies of imetelstat consist of IMerge™.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    GeronUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    149 Commonwealth Drive Menlo Park, CA 94025
    Telephone
    Telephone
    650-473-7700
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.geron.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/geron
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Geron Plots Deep Layoffs In Bid To Curb Operating Costs
    Geron Plots Deep Layoffs In Bid To Curb Operating Costs

    11 Dec 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/geron-lay-13-workforce-quest-slash-operating-costs-maximize-rytelo-launch

    FIERCE PHARMA
    11 Dec 2025
    Share Share
    Geron Corp. Reveals Q3 2025 Financials & Business Updates
    Geron Corp. Reveals Q3 2025 Financials & Business Updates

    05 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251105396283/en/Geron-Corporation-Reports-Third-Quarter-2025-Financial-Results-and-Recent-Business-Highlights

    BUSINESSWIRE
    05 Nov 2025
    Share Share
    Geron Corporation To Present At Upcoming Investor Conferences
    Geron Corporation To Present At Upcoming Investor Conferences

    04 Nov 2025

    // BUSINESS WIRE

    https://www.businesswire.com/news/home/20251104230656/en/Geron-Corporation-to-Present-at-Upcoming-Investor-Conferences

    BUSINESS WIRE
    04 Nov 2025
    Share Share
    Geron To Unveil Q3 2025 Financial Results On Nov 5, 2025
    Geron To Unveil Q3 2025 Financial Results On Nov 5, 2025

    27 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251027127382/en/Geron-Plans-to-Announce-Third-Quarter-2025-Financial-Results-on-November-5-2025

    BUSINESSWIRE
    27 Oct 2025
    Share Share
    Geron Corp. Discloses Inducement Grants Per Nasdaq LR 5635(C)(4)
    Geron Corp. Discloses Inducement Grants Per Nasdaq LR 5635(C)(4)

    20 Oct 2025

    // BUSINESS WIRE

    https://www.businesswire.com/news/home/20251020724593/en/Geron-Corporation-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4

    BUSINESS WIRE
    20 Oct 2025
    Share Share
    Geron Corp Reveals Executive Leadership Changes
    Geron Corp Reveals Executive Leadership Changes

    13 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/13/3165821/35501/en/Geron-Corporation-Announces-Executive-Leadership-Transitions-and-Appointments.html

    GLOBENEWSWIRE
    13 Oct 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Contact Geron and get a quotation

    Geron is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find a price of Sodium DNA bulk offered by Geron

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search